NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is an incurable B-cell neoplasm characterized by highly variable clinical outcomes. In recent years, genomic and molecular studies revealed a remarkable heterogeneity in CLL, which mirrored the clinical diversity of this disease. These studies profoundly enhanced o...
Main Authors: | Emanuela Rosati, Stefano Baldoni, Filomena De Falco, Beatrice Del Papa, Erica Dorillo, Chiara Rompietti, Elisa Albi, Franca Falzetti, Mauro Di Ianni, Paolo Sportoletti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00229/full |
Similar Items
-
NOTCH and Graft-Versus-Host Disease
by: Mauro Di Ianni, et al.
Published: (2018-08-01) -
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
by: Paolo Sportoletti, et al.
Published: (2021-06-01) -
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential
by: Estevão Carlos Silva Barcelos, et al.
Published: (2023-09-01) -
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL
by: Filomena De Falco, et al.
Published: (2022-09-01) -
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia
by: Francesco Maria Adamo, et al.
Published: (2023-07-01)